YF-VAX 1 dose vials
Ended Awarded
- Contract number
- SPE2DB25FYW74
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,753
Award facts
- Contract value 100% obligated
- $41,753.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $41,753.25 by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of YF-VAX 1 Dose Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of June 24, 2025, and was awarded without a set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that enables the agency to issue delivery orders for comprehensive pharmaceutical products supporting military healthcare facilities worldwide.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, providing pharmaceutical products and medical supplies directly to Department of Defense healthcare sites. The company's extensive portfolio includes prescription medications, biologics, vaccines, and medical consumables across various categories. The YF-VAX delivery under this order supports the DLA's mission to supply vaccines and immunological products to military and federal healthcare systems, consistent with the company's demonstrated expertise in delivering specialized pharmaceutical products to government medical facilities.
Quick answers
Who was awarded contract SPE2DB25FYW74?
SPE2DB25FYW74 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FYW74 worth?
The government has obligated $41,753 on SPE2DB25FYW74.
Is contract SPE2DB25FYW74 an order under another contract?
Yes. SPE2DB25FYW74 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYW74 competed?
The extent of competition for SPE2DB25FYW74 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award